Characterization of a Cannabinoid CB2 Receptor-Selective Agonist, A-836339 [2,2,3,3-Tetramethyl-cyclopropanecarboxylic Acid [3-(2-Methoxy-ethyl)-4,5-dimethyl-3 H-thiazol-(2 Z)-ylidene]-amide], Using in Vitro Pharmacological Assays, in Vivo Pain Models, and Pharmacological Magnetic Resonance Imaging

A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man

Bennett, G. J., & Xie, Y.-K. (1988) · Pain · doi:10.1016/0304-3959(88)90209-6 · Cited by 5,376 · see citing works

A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia

Hargreaves, K., Dubner, R. A., Brown, F. J., Flores, C., & Joris, J. L. (1988) · Pain · doi:10.1016/0304-3959(88)90026-7 · Cited by 5,155 · see citing works

Molecular characterization of a peripheral receptor for cannabinoids

Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · see citing works

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011 · see citing works

Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations

Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D. J., Fur, G. L., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,751 · see citing works

Characterization of a rat model of incisional pain

Brennan, T. J., Vandermeulen, E., & Gebhart, G. F. (1996) · Pain · doi:10.1016/0304-3959(95)01441-1 · Cited by 1,101 · see citing works

Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.

Felder, C., Joyce, K. E., Briley, E. M., Mansouri, J., Mackie, K., Blond, O., Lai, Y., Ma, A. L., & Mitchell, R. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10492-6 · Cited by 900 · see citing works

HU-308: A specific agonist for CB 2 , a peripheral cannabinoid receptor

Hanus, L. O., Breuer, A., Tchilibon, S., Shiloah, S., Goldenberg, D., Horowitz, M., Pertwee, R. G., Ross, R. A., Mechoulam, R., & Fride, E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14228 · Cited by 574 · see citing works

CB ₂ cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids

Ibrahim, M. M., Porreca, F., Lai, J., Albrecht, P. J., Rice, F. L., Khodorova, A., Davar, G., Makriyannis, A., Vanderah, T. W., Mata, H. P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409888102 · Cited by 521 · see citing works

Cannabinoid CB ₂ receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain

Guindon, J., & Hohmann, A. G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707531 · Cited by 423 · see citing works

Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models

Zhang, J., Hoffert, C., Vu, H. K., Groblewski, T., Ahmad, S., & O'Donnell, D. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02704.x · Cited by 419 · see citing works

CB2 cannabinoid receptor-mediated peripheral antinociception

Malan, P. T., Ibrahim, M. M., Deng, H., Liu, Q., Mata, H. P., Vanderah, T., Porreca, F., & Makriyannis, A. (2001) · Pain · doi:10.1016/s0304-3959(01)00321-9 · Cited by 391 · see citing works

The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain

Fox, A., Kesingland, A., Gentry, C., McNair, K., Patel, S., Urban, L., & James, I. (2001) · Pain · doi:10.1016/s0304-3959(00)00474-7 · Cited by 379 · see citing works

Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy

Valenzano, K. J., Tafesse, L., Lee, G., Harrison, J. E., Boulet, J. M., Gottshall, S. L., Mark, L., Pearson, M. S., Miller, W., Shan, S., et al. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.12.008 · Cited by 288 · see citing works

Cannabis, Pain, and Sleep: Lessons from Therapeutic Clinical Trials of Sativex®, a Cannabis‐Based Medicine

Russo, E. B., Guy, G. W., & Robson, P. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790150 · Cited by 228 · see citing works

Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor

Shire, D. J., Calandra, B., Rinaldi, M. L., Oustric, D., Pessègue, B., Bonnin, O., Fur, G. L., Caput, D., & Ferrara, P. (1996) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(96)00047-4 · Cited by 208 · see citing works

Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase.

Slipetz, D. M., O’Neill, G. P., Favreau, L., Dufresne, C., Gallant, M., Gareau, Y., Guay, D., Labelle, M., & Metters, K. M. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10254-x · Cited by 191 · see citing works

CB2 cannabinoid receptor mediation of antinociception

Ibrahim, M. M., Rude, M. L., Stagg, N. J., Mata, H. P., Lai, J. Y., Vanderah, T. W., Porreca, F., Buckley, N. E., Makriyannis, A., & Malan, P. T. (2006) · Pain · doi:10.1016/j.pain.2005.12.018 · Cited by 172 · see citing works

<i>In vitro</i>and<i>in vivo</i>characterization of A‐796260: a selective cannabinoid CB₂receptor agonist exhibiting analgesic activity in rodent pain models

Yao, B. B., Hsieh, G. C., Frost, J. M., Fan, Y., Garrison, T. R., Daza, A. V., Grayson, G. K., Zhu, C. Z., Pai, M., Chandran, P., et al. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707568 · Cited by 140 · see citing works

Cannabimimetic lndoles, Pyrroles and lndenes

Huffman, J. W. (1999) · Current Medicinal Chemistry · doi:10.2174/0929867306666220401125055 · Cited by 134 · see citing works

Selective Activation of Cannabinoid CB2 Receptors Suppresses Hyperalgesia Evoked by Intradermal Capsaicin

Hohmann, A. G., Farthing, J. N., Zvonok, A. M., & Makriyannis, A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060079 · Cited by 123 · see citing works

Cannabimimetic indoles, pyrroles and indenes.

Huffman, J. W. (1999) · PubMed · Cited by 123 · see citing works

Discovery of 2-[(2,4-Dichlorophenyl)amino]- N -[(tetrahydro- 2 H -pyran-4-yl)methyl]-4-(trifluoromethyl)- 5-pyrimidinecarboxamide, a Selective CB2 Receptor Agonist for the Treatment of Inflammatory Pain

Giblin, G. M. P., O’Shaughnessy, C. T., Naylor, A., Mitchell, W. L., Eatherton, A. J., Slingsby, B. P., Rawlings, D. A., Goldsmith, P., Brown, A. J., Haslam, C. P., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061195+ · Cited by 121 · see citing works

In vitropharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2receptor?

Yao, B. B., Mukherjee, S., Fan, Y., Garrison, T. R., Daza, A. V., Grayson, G. K., Hooker, B. A., Dart, M. J., Sullivan, J. P., & Meyer, M. D. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706838 · Cited by 118 · see citing works

Age-Dependent Opioid Escalation in Chronic Pain Patients

Buntin-Mushock, C., Phillip, L., Moriyama, K., & Pierce, P. A. (2005) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000152191.29311.9b · Cited by 104 · see citing works

Comparison of antinociceptive actions of standard analgesics in attenuating capsaicin and nerve-injury-induced mechanical hypersensitivity

Joshi, S. K., Hernandez, G., Mikusa, J. P., Zhu, C. Z., Zhong, C., Salyers, A. K., Wismer, C. T., Chandran, P., Decker, M. W., & Honoré, P. H. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.005 · Cited by 100 · see citing works

New class of potent ligands for the human peripheral cannabinoid receptor

Gallant, M., Dufresne, C., Gareau, Y., Guay, D., Leblanc, Y., Prasit, P., Rochette, C., Sawyer, N., Slipetz, D. M., Tremblay, N. M., et al. (1996) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(96)00426-x · Cited by 97 · see citing works

Activation of CB1 and CB2 receptors attenuates the induction and maintenance of inflammatory pain in the rat

Elmes, S. J. R., Winyard, L. A., Medhurst, S. J., Clayton, N. M., Wilson, A. W., Kendall, D. A., & Chapman, V. (2005) · Pain · doi:10.1016/j.pain.2005.09.005 · Cited by 97 · see citing works

Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI

Chin, C.-L., Tovcimak, A. E., Hradil, V. P., Seifert, T. R., Hollingsworth, P. R., Chandran, P., Zhu, C. Z., Gauvin, D. M., Pai, M., Wetter, J. B., et al. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707506 · Cited by 96 · see citing works

A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833

Whiteside, G. T., Gottshall, S. L., Boulet, J. M., Chaffer, S. M., Harrison, J., Pearson, M. S., Turchin, P. I., Mark, L., Garrison, A. E., & Valenzano, K. J. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.10.043 · Cited by 94 · see citing works

Species‐specificin vitropharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers

Bingham, B., JONES, P. G., Uveges, A. J., Kotnis, S., Lu, P., Smith, V. A., Sun, S., Resnick, L., Chlenov, M., He, Y., et al. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707303 · Cited by 93 · see citing works

Involvement of central cannabinoid CB2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain

Yamamoto, W., Mikami, T., & Iwamura, H. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.010 · Cited by 89 · see citing works

Novel, Not Adenylyl Cyclase-Coupled Cannabinoid Binding Site in Cerebellum of Mice

Monory, K., Tzavara, E. T., Lexime, J., Ledent, C. A., Parmentier, M., Borsodi, A. D., & Hanoune, J. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6635 · Cited by 75 · see citing works

Morphine-induced analgesic tolerance, locomotor sensitization and physical dependence do not require modification of mu opioid receptor, cdk5 and adenylate cyclase activity

Contet, C., Filliol, D., Matifas, A., & Kieffer, B. L. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.10.015 · Cited by 68 · see citing works

Therapeutic potential of cannabinoid receptor agonists as analgesic agents

Fox, A., & Bevan, S. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.6.695 · Cited by 60 · see citing works

Imine derivatives as new potent and selective CB2 cannabinoid receptor agonists with an analgesic action

Ohta, H., Ishizaka, T., Tatsuzuki, M., Yoshinaga, M., Iida, I., Yamaguchi, T., Tomishima, Y., Futaki, N., Toda, Y., & Saito, S. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.10.087 · Cited by 44 · see citing works

Interventional Approaches to Pain Management

Markman, J. D., & Philip, A. G. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2006.10.015 · Cited by 35 · see citing works

A CB2 receptor agonist, A-836339, modulates wide dynamic range neuronal activity in neuropathic rats: Contributions of spinal and peripheral CB2 receptors

McGaraughty, S., Chu, K. L., Dart, M. J., Yao, B. B., & Meyer, M. D. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.015 · Cited by 31 · see citing works

Characterization of Cannabinoid Modulation of Sensory Neurotransmission in the Rat Isolated Mesenteric Arterial Bed

Duncan, M., Kendall, D. A., & Ralevic, V. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.067587 · Cited by 23 · see citing works

Interventional Approaches to Pain Management

Markman, J. D., & Philip, A. G. (2007) · Anesthesiology Clinics · doi:10.1016/j.anclin.2007.07.012 · Cited by 19 · see citing works

New pharmacological strategies for pain relief

Gillen, C., & Maul, C. (2002) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2.5.691 · Cited by 3 · see citing works

CB2: a cannabinoid receptor with an identity crisis

Atwood, B. K., & Mackie, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00729.x · Cited by 633 · see citing works

Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside

Rahn, E. J., & Hohmann, A. G. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.08.002 · Cited by 305 · see citing works

The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain

Donvito, G., Nass, S. R., Wilkerson, J. L., Curry, Z. A., Schurman, L. D., Kinsey, S. G., & Lichtman, A. H. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.204 · Cited by 301 · see citing works

Chronic Cannabinoid Receptor 2 Activation Reverses Paclitaxel Neuropathy Without Tolerance or Cannabinoid Receptor 1–Dependent Withdrawal

Deng, L., Guindon, J., Cornett, B., Makriyannis, A., Mackie, K., & Hohmann, A. G. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.04.009 · Cited by 200 · see citing works

Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years

Maccarrone, M., Di Marzo, V., Gertsch, J., Grether, U., Howlett, A. C., Hua, T., Makriyannis, A., Piomelli, D., Ueda, N., & van der Stelt, M. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000600 · Cited by 183 · see citing works

Functional Selectivity in CB2 Cannabinoid Receptor Signaling and Regulation: Implications for the Therapeutic Potential of CB2 Ligands

Atwood, B. K., Wager‐Miller, J., Haskins, C. P., Straiker, A. J., & Mackie, K. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.074013 · Cited by 152 · see citing works

Central and peripheral sites of action for CB ₂ receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats

Hsieh, G. C., Pai, M., Chandran, P., Hooker, B. A., Zhu, C. Z., Salyers, A. K., Wensink, E. J., Zhan, C., Carroll, W. A., Dart, M. J., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01046.x · Cited by 139 · see citing works

Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists

Han, S., Thatte, J., Buzard, D. J., & Jones, R. M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4005626 · Cited by 134 · see citing works

Heteromerization of GPR 55 and cannabinoid CB 2receptors modulates signalling

Balenga, N. A. B., Martínez‐Pinilla, E., Kargl, J., Schröder, R. J., Peinhaupt, M., Platzer, W., Bálint, Z., Zamarbide, M., Dopeso‐Reyes, I. G., Ricobaraza, A., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12850 · Cited by 128 · see citing works

The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonist New Psychoactive Substances: Evolution

Banister, S. D., & Connor, M. A. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_144 · Cited by 126 · see citing works

PET Imaging of Microglial Activation—Beyond Targeting TSPO

Janssen, B., Vugts, D. J., Windhorst, A. D., & Mach, R. H. (2018) · Molecules · doi:10.3390/molecules23030607 · Cited by 127 · see citing works

Current evidence of cannabinoid‐based analgesia obtained in preclinical and human experimental settings

Lötsch, J., Weyer-Menkhoff, I., & Tegeder, I. (2017) · European Journal of Pain · doi:10.1002/ejp.1148 · Cited by 118 · see citing works

Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2Receptor Agonists

Tabrizi, M. A., Baraldi, P. G., Borea, P. A., & Varani, K. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00411 · Cited by 110 · see citing works

Synthesis and biodistribution of [11C]A-836339, a new potential radioligand for PET imaging of cannabinoid type 2 receptors (CB2)

Horti, A. G., Gao, Y., Ravert, H. T., Finley, P. A., Valentine, H., Wong, D. F., Endres, C. J., Savonenko, A. V., & Dannals, R. F. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.05.058 · Cited by 108 · see citing works

Modulating the delicate glial–neuronal interactions in neuropathic pain: Promises and potential caveats

Tiwari, V., Guan, Y., & Raja, S. N. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.05.002 · Cited by 103 · see citing works

The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects

Kinsey, S. G., Mahadevan, A., Zhao, B., Sun, H., Naidu, P. S., Razdan, R. K., Selley, D. E., Damaj, M. I., & Lichtman, A. H. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.09.004 · Cited by 94 · see citing works

Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation

Savonenko, A. V., Melnikova, T., Wang, Y., Ravert, H. T., Gao, Y., Koppel, J. L., Lee, D., Pletniková, O., Cho, E., Sayyida, N., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129618 · Cited by 93 · see citing works

2,3‐Dihydro‐1‐Benzofuran Derivatives as a Series of Potent Selective Cannabinoid Receptor 2 Agonists: Design, Synthesis, and Binding Mode Prediction through Ligand‐Steered Modeling

Diaz, P., Phatak, S. S., Xu, J. J., Fronczek, F. R., Astruc‐Diaz, F., Thompson, C. M., Cavasotto, C. N., & Naguib, M. (2009) · ChemMedChem · doi:10.1002/cmdc.200900226 · Cited by 88 · see citing works

Latest advances in cannabinoid receptor agonists

Thakur, G. A., Tichkule, R. B., Bajaj, S., & Makriyannis, A. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770903436505 · Cited by 87 · see citing works

Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands

Davis, M. P. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.918603 · Cited by 79 · see citing works

Dynamic changes to the endocannabinoid system in models of chronic pain

Sagar, D. R., Burston, J. J., Woodhams, S. G., & Chapman, V. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0390 · Cited by 76 · see citing works

Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future

Whiting, Z. M., Yin, J., de la Harpe, S. M., Vernall, A. J., & Grimsey, N. L. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.06.010 · Cited by 70 · see citing works

Cannabinoid CB2 Agonist AM1710 Differentially Suppresses Distinct Pathological Pain States and Attenuates Morphine Tolerance and Withdrawal

Li, A.-L., Lin, X., Dhopeshwarkar, A., Thomaz, A. C., Carey, L. M., Liu, Y., Nikas, S. P., Makriyannis, A., Mackie, K., & Hohmann, A. G. (2018) · Molecular Pharmacology · doi:10.1124/mol.118.113233 · Cited by 69 · see citing works

Novel thiazole derivatives: a patent review (2008 – 2012. Part 2)

Leoni, A., Locatelli, A., Morigi, R., & Rambaldi, M. (2014) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2014.910196 · Cited by 67 · see citing works

Synthetic cannabinoids abused in South Korea: drug identifications by the National Forensic Service from 2009 to June 2013

Chung, H., Choi, H., Heo, S., Kim, E., & Lee, J. (2013) · Forensic Toxicology · doi:10.1007/s11419-013-0213-6 · Cited by 62 · see citing works

CB1 Knockout Mice Unveil Sustained CB2-Mediated Antiallodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain

Deng, L., Cornett, B., Mackie, K., & Hohmann, A. G. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.098483 · Cited by 60 · see citing works

Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury

Brownjohn, P. W., & Ashton, J. C. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.12.028 · Cited by 57 · see citing works

Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in mice

Wiley, J. L., Lefever, T. W., Marusich, J. A., Grabenauer, M., Moore, K. N., Huffman, J. W., & Thomas, B. F. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.07.016 · Cited by 58 · see citing works

Development of a High-Affinity PET Radioligand for Imaging Cannabinoid Subtype 2 Receptor

Moldovan, R., Teodoro, R., Gao, Y., Deuther‐Conrad, W., Kranz, M., Wang, Y., Kuwabara, H., Nakano, M., Valentine, H., Fischer, S., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00554 · Cited by 58 · see citing works

Discovery of S-777469: An orally available CB2 agonist as an antipruritic agent

Odan, M., Ishizuka, N., Hiramatsu, Y., Inagaki, M., Hashizume, H., Fujii, Y., Mitsumori, S., Morioka, Y., Soga, M., Deguchi, M., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.02.072 · Cited by 56 · see citing works

CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor pain

Khasabova, I. A., Gielissen, J. M., Chandiramani, A., Harding-Rose, C., Odeh, D. A., Simone, D. A., & Seybold, V. S. (2011) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283474a6d · Cited by 53 · see citing works

Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal anti‐inflammatory cytokine responses in neuropathic rats exhibiting relief from allodynia

Wilkerson, J. L., Gentry, K. R., Dengler, E. C., Wallace, J. A., Kerwin, A. A., Kuhn, M. N., Zvonok, A. M., Thakur, G. A., Makriyannis, A., & Milligan, E. D. (2012) · Brain and Behavior · doi:10.1002/brb3.44 · Cited by 51 · see citing works

Cannabinoid receptors and pain

Starowicz, K., Małek, N., & Przewłocka, B. (2013) · Wiley Interdisciplinary Reviews Membrane Transport and Signalling · doi:10.1002/wmts.83 · Cited by 50 · see citing works

Cannabinoid-mediated targeting of mitochondria on the modulation of mitochondrial function and dynamics

Malheiro, R. F., Carmo, H., Carvalho, F. D., & Silva, J. P. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106603 · Cited by 47 · see citing works

Development of brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer's disease

Janssen, B., & Mach, R. H. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.04.005 · Cited by 45 · see citing works

Tolerance to chronic delta-9-tetrahydrocannabinol (Δ⁹-THC) in rhesus macaques infected with simian immunodeficiency virus.

Winsauer, P. J., Molina, P. E., Amedee, A. M., Filipeanu, C. M., McGoey, R. R., Troxclair, D. A., Walker, E. M., Birke, L. L., Stouwe, C. V., Howard, J. M., et al. (2011) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0023000 · Cited by 44 · see citing works

Endocannabinoid Receptor Pharmacology

Yao, B. B., & Mackie, K. (2009) · Current topics in behavioral neurosciences · doi:10.1007/978-3-540-88955-7_2 · Cited by 43 · see citing works

The exogenous administration of CB2 specific agonist, GW405833, inhibits inflammation by reducing cytokine production and oxidative stress

Parlar, A., Arslan, S. O., Doğan, M. F., Çam, S. A., Yal�in, A., Elibol, E., �zer, M., ��kardeş, F., & Kara, H. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6753 · Cited by 43 · see citing works

Mechanisms of cannabinoid tolerance

Piscura, M. K., Henderson, A. N., Barnes, R. C., Mitra, S., Guindon, J., & Morgan, D. J. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115665 · Cited by 38 · see citing works

Radioligands for positron emission tomography imaging of cannabinoid type 2 receptor

Spinelli, F., Mu, L., & Ametamey, S. M. (2017) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3579 · Cited by 36 · see citing works

Allergen Challenge Increases Anandamide in Bronchoalveolar Fluid of Patients With Allergic Asthma

Zoerner, A. A., Stichtenoth, D. O., Engeli, S., Bátkai, S., Winkler, C., Schaumann, F., Janke, J., Holz, O., Krug, N., Tsikas, D., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.94 · Cited by 35 · see citing works

S-777469, a Novel Cannabinoid Type 2 Receptor Agonist, Suppresses Itch-Associated Scratching Behavior in Rodents through Inhibition of Itch Signal Transmission

Haruna, T., Soga, M., Morioka, Y., Hikita, I., Imura, K., Furue, Y., Yamamoto, M., Imura, C., Ikeda, M., Yamauchi, A., et al. (2015) · Pharmacology · doi:10.1159/000371890 · Cited by 34 · see citing works

Combination Chemistry: Structure–Activity Relationships of Novel Psychoactive Cannabinoids

Wiley, J. L., Marusich, J. A., & Thomas, B. F. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_17 · Cited by 33 · see citing works

Three-dimensional quantitative structure–selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2

Brogi, S., Corelli, F., Marzo, V. D., Ligresti, A., Mugnaini, C., Pasquini, S., & Tafi, A. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.11.034 · Cited by 33 · see citing works

A CB2 receptor agonist, A-836339, modulates wide dynamic range neuronal activity in neuropathic rats: Contributions of spinal and peripheral CB2 receptors

McGaraughty, S., Chu, K. L., Dart, M. J., Yao, B. B., & Meyer, M. D. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.015 · Cited by 31 · see citing works

Legal controls on cannabimimetics: An international dilemma?

King, L. A. (2013) · Drug Testing and Analysis · doi:10.1002/dta.1510 · Cited by 31 · see citing works

Synthesis and SAR of novel imidazoles as potent and selective cannabinoid CB2 receptor antagonists with high binding efficiencies

Lange, J. H. M., van der Neut, M. A. W., Wals, H. C., Kuil, G. D., Borst, A. J. M., Mulder, A. T., den Hartog, A. P., Zilaout, H., Goutier, W., van Stuivenberg, H. H., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.12.032 · Cited by 31 · see citing works

Inflammation in Experimental Models of α ‐Synucleinopathies

Harms, A. S., Kordower, J. H., Sette, A., Arlehamn, C. S. L., Sulzer, D. L., & Mach, R. H. (2020) · Movement Disorders · doi:10.1002/mds.28264 · Cited by 30 · see citing works

Cholesterol as a modulator of cannabinoid receptor CB2 signaling

Yeliseev, A., Iyer, M. R., Joseph, T. T., Coffey, N. J., Çınar, R., Zoubak, L., Kunos, G., & Gawrisch, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-83245-6 · Cited by 28 · see citing works

The CB2 cannabinoid receptor as a therapeutic target in the central nervous system

Cabañero, D., Martín‐García, E., & Maldonado, R. J. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1971196 · Cited by 29 · see citing works

From Structure–Activity Relationships on Thiazole Derivatives to the In Vivo Evaluation of a New Radiotracer for Cannabinoid Subtype 2 PET Imaging

Caillé, F., Cacheux, F., Peyronneau, M., Jégo, B., Jaumain, E., Pottier, G., Ullmer, C., Grether, U., Winkeler, A., Dollé, F., et al. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00746 · Cited by 27 · see citing works

Development of fluorinated CB2 receptor agonists for PET studies

Lueg, C., Schepmann, D., Günther, R., Brust, P., & Wünsch, B. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.09.040 · Cited by 26 · see citing works

Antinociceptive Effects of Racemic AM1241 and Its Chirally Synthesized Enantiomers: Lack of Dependence upon Opioid Receptor Activation

Rahn, E. J., Zvonok, A. M., Makriyannis, A., & Hohmann, A. G. (2010) · The AAPS Journal · doi:10.1208/s12248-009-9170-8 · Cited by 24 · see citing works

Antinociceptive effects induced through the stimulation of spinal cannabinoid type 2 receptors in chronically inflamed mice

Curto-Reyes, V., Boto, T., Hidalgo, A., Menéndez, L., & Baamonde, A. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.06.057 · Cited by 24 · see citing works

Translational NeuroImaging of the CNS: Novel Pathways to Drug Development

Fox, G. B., Chin, C.-L., Luo, F. R., Day, M., & Cox, B. F. (2009) · Molecular Interventions · doi:10.1124/mi.9.6.6 · Cited by 22 · see citing works

Behavioral Neurobiology of the Endocannabinoid System

Kendall, D., & Alexander, S. (2009) · Current topics in behavioral neurosciences · doi:10.1007/978-3-540-88955-7 · Cited by 22 · see citing works

Novel strategies for the treatment of inflammatory hyperalgesia

Chopade, A. R., & Mulla, W. A. (2010) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-010-0784-7 · Cited by 21 · see citing works

Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular Probes

Basagni, F., Rosini, M., & Decker, M. W. (2020) · ChemMedChem · doi:10.1002/cmdc.202000298 · Cited by 21 · see citing works

Convenient Multicomponent One‐Pot Synthesis of 2‐Iminothiazolines and 2‐Aminothiazoles Using Elemental Sulfur Under Aqueous Conditions

Németh, A. G., Marlok, B., Domján, A., Gao, Q., Han, X., Keserű, G. M., & Ábrányi‐Balogh, P. (2021) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202100548 · Cited by 20 · see citing works

The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief

Wilkerson, J. L., & Milligan, E. D. (2011) · ISRN Anesthesiology · doi:10.5402/2011/593894 · Cited by 20 · see citing works

The mystery behind the apprehensions of the selective cannabinoid receptor type-2 agonist BZO-HEXOXIZID (MDA-19) as a drug of abuse

de Araújo, K. R. G., Fábris, A. L. D. S., Júnior, L. F. N., Ponce, J. D. C., Soares, A. L., Costa, J. L. R., & Yonamine, M. (2022) · Forensic Toxicology · doi:10.1007/s11419-022-00646-6 · Cited by 16 · see citing works

Highly selective CB2 receptor agonist A836339 has gastroprotective effect on experimentally induced gastric ulcers in mice

Sałaga, M., Zatorski, H., Zielińska, M., Mosińska, P., Timmermans, J., Kordek, R., Storr, M., & Fichna, J. (2017) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-017-1402-3 · Cited by 15 · see citing works

Role of Nuclear Imaging to Understand the Neural Substrates of Brain Disorders in Laboratory Animals: Current Status and Future Prospects

D’Elia, A., Schiavi, S., Soluri, A., Massari, R., Soluri, A., & Trezza, V. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.596509 · Cited by 14 · see citing works

Discovery of 4-(1,2,4-Oxadiazol-5-yl)azepan-2-one Derivatives as a New Class of Cannabinoid Type 2 Receptor Agonists for the Treatment of Inflammatory Pain

Nan, J., Liu, J., Lin, G., Zhang, S., Xia, A., Zhou, P., Zhou, Y., Zhang, J., Zhao, J., Zhang, S., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01943 · Cited by 14 · see citing works

Cannabinoid CB2 receptor‐mediated analgesia: mechanism‐based insights and therapeutic potential

Guenther, K. G., & Hohmann, A. G. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70116 · Cited by 12 · see citing works

Identification of a synthetic cannabinoid A-836339 as a novel compound found in a product

Uemura, N., Fukaya, H., Kanai, C., Yoshida, M., Nakajima, J., Takahashi, M., Suzuki, J., Moriyasu, T., & Nakae, D. (2013) · Forensic Toxicology · doi:10.1007/s11419-013-0201-x · Cited by 12 · see citing works

Development of the High-Affinity Carborane-Based Cannabinoid Receptor Type 2 PET Ligand [18F]LUZ5-d8

Ueberham, L., Gündel, D., Kellert, M., Deuther‐Conrad, W., Ludwig, F., Lönnecke, P., Kazimir, A., Kopka, K., Brust, P., Moldovan, R., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00195 · Cited by 11 · see citing works

Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB2 receptor agonists for pain management

Nelson, D. W., Frost, J. M., Tietje, K. R., Florjancic, A. S., Ryther, K. B., Carroll, W. A., Dart, M. J., Daza, A. V., Hooker, B. A., Grayson, G. K., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.01.121 · Cited by 11 · see citing works

PET Imaging of Endocannabinoid System

Horti, A. G., Raymont, V., & Terry, G. E. (2014) · Springer eBooks · doi:10.1007/978-3-642-42014-6_11 · Cited by 11 · see citing works

First-in-human imaging using [11C]MDTC: a radiotracer targeting the cannabinoid receptor type 2

Du, Y., Coughlin, J. M., Brosnan, M. K., Chen, A. R., Shinehouse, L. K., Abdallah, R. H., Lodge, M. A., Mathews, W. B., Liu, C., Wu, Y., et al. (2023) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-023-06170-y · Cited by 10 · see citing works

Development of fluorinated and methoxylated benzothiazole derivatives as highly potent and selective cannabinoid CB2 receptor ligands

Aly, M. W., Ludwig, F., Deuther‐Conrad, W., Brust, P., Abadi, A., Moldovan, R., & Osman, N. A. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105191 · Cited by 9 · see citing works

Chapter 11 Recent Advances in the Discovery of CB2 Selective Agonists

Han, S., Thatte, J., & Jones, R. M. (2009) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(09)04411-x · Cited by 9 · see citing works

A systematic review of novel cannabinoids and their targets: Insights into the significance of structure in activity

Hamzekalayi, M. R. A., Ardakani, M. H., Moeini, Z., Rezaei, R., Hamidi, N., Somee, L. R., Zolfaghar, M., Darzi, R., kamalipourazad, M., Riazi, G. H., et al. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176679 · Cited by 7 · see citing works

Novel targets in pain research: The case for CB2 receptors as a biorational pain target

Brownjohn, P. W., & Ashton, J. C. (2009) · Current Anaesthesia and Critical Care · doi:10.1016/j.cacc.2009.07.014 · Cited by 7 · see citing works

Translational Preclinical PET Imaging and Metabolic Evaluation of a New Cannabinoid 2 Receptor (CB2R) Radioligand, (Z)-N-(3-(2-(2-[18F]Fluoroethoxy)ethyl)-4,5-dimethylthiazol-2(3H)-ylidene)-2,2,3,3-tetramethylcyclopropane-1-carboxamide

Auvity, S., Attili, B. N. N. R., Caillé, F., Goislard, M., Cayla, J., Hinnen, F., Demphel, S., Brulon, V., Bottlaender, M., Leroy, C., et al. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00348 · Cited by 5 · see citing works

PET Imaging of the Endocannabinoid System

Terry, G. E., Raymont, V., & Horti, A. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53176-8_12 · Cited by 5 · see citing works

Acute cannabidiol (CBD), tetrahydrocannabinol (THC) and their mixture (THC:CBD) exert differential effects on brain activity and blood flow in rats: A translational neuroimaging study

MacNicol, E., Kokkinou, M., Navacerrada, M. E. S., Smith, D.-M., Li, J. S. Y., Simmons, C., Kim, E., Mesquita, M. S., Gonzalez, L. R., Andrews, T., et al. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251360745 · Cited by 4 · see citing works

Glial Modulation in Pain States: Translation into Humans

Horvath, R. J., Romero-Sandoval, E. A., & Leo, J. A. D. (2010) · Europe PMC (PubMed Central) · Cited by 3 · see citing works

Combined Endocannabinoid and Cyclooxygenase Inhibition Additively Attenuates Post-Surgical Pain

Rodriguez, C. E. B., Vanegas, S. O., Reck, A. M., Schrom, Y., & Kinsey, S. G. (2025) · Cannabis and Cannabinoid Research · doi:10.1089/can.2024.0088 · Cited by 2 · see citing works

Reduced Antinociceptive Effect of Repeated Treatment with a Cannabinoid Receptor Type 2 Agonist in Cannabinoid-Tolerant Rats Following Spinal Nerve Transection

Matthew, S., Ndong, C., Landry, R. P., Joyce, A., & Alfonso, E. (2012) · InTech eBooks · doi:10.5772/31686 · Cited by 2 · see citing works

Cannabinoid receptors as targets for drug discovery

Iliopoulos‐Tsoutsouvas, C., Iyer, M. R., & Makriyannis, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00052-2 · Cited by 1 · see citing works

Pain therapeutics

Bannon, A. W. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511980053.010 · Cited by 1 · see citing works

Humanized CB1R and CB2R yeast biosensors enable facile screening of cannabinoid compoundsPreprint

Mulvihill, C. J., Lutgens, J., Gollihar, J., Bachanová, P., Marcotte, E. M., Ellington, A. D., & Gardner, E. C. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.12.511978 · Cited by 1 · see citing works

Applications of MRI to Psychopharmacology

Stein, D. J., Yang, Y., & Salmeron, B. J. (2011) · Springer eBooks · doi:10.1007/978-1-4419-0345-7_33

2,2,3,3-Tetramethylcyclopropanecarboxylic acid [3-(2-[11C]methoxyethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]amide

Leung, K. (2011) · National Center for Biotechnology Information (US) eBooks

Applications of MRI to Psychopharmacology

Stein, D. J., Yang, Y., & Salmeron, B. J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1995-6_19

Current World Literature

(2010) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0b013e3283372479

Applications of MRI to Psychopharmacology

Stein, D. J., Yang, Y., & Salmeron, B. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-10909-6_37

Development of Carborane‐Based Halogenated Naphthyridinone‐Analogues as Cannabinoid Receptor Type 2 (CB 2 R) Ligands

Ueberham, L., Deuther‐Conrad, W., Lönnecke, P., Kazimir, A., & Hey‐Hawkins, E. (2025) · ChemMedChem · doi:10.1002/cmdc.202500251

Advanced Protein Modeling Method: Benchmarking and Applications in Computer-Aided Drug Discovery

Phatak, S. S. (2012) · Digital Commons-TMC (Texas Medical Center)

Genetically Encoded CB2R-Based Fluorescent Sensor Enables Rapid Screening and Functional Assessment of Cannabinoid Modulators

Bhattacharjee, P., Volesky, P. D., Shivshankar, S., Puhl, H. L., & Iyer, M. R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052095

BindingDB Entry 50039289: Synthesis and biodistribution of [11C]A-836339, a new potential radioligand for PET imaging of cannabinoid type 2 receptors (CB2).

BindingDB (2013) · UC San Diego · doi:10.7270/q2668f56

BindingDB Entry 50005808: Development of fluorinated CB(2) receptor agonists for PET studies.

BindingDB (2020) · UC San Diego · doi:10.7270/q2q2435t

BindingDB Entry 50039540: Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB2 receptor agonists for pain management.

BindingDB (2013) · UC San Diego · doi:10.7270/q2fn1765

BindingDB Entry 50032871: Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2.

BindingDB (2011) · UC San Diego · doi:10.7270/q2cf9qcj

BindingDB Entry 50039610: Discovery of S-777469: an orally available CB2 agonist as an antipruritic agent.

BindingDB (2013) · UC San Diego · doi:10.7270/q2db82vv

BindingDB Entry 50019753: Discovery of 4-(1,2,4-Oxadiazol-5-yl)azepan-2-one Derivatives as a New Class of Cannabinoid Type 2 Receptor Agonists for the Treatment of Inflammatory Pain.

BindingDB (2024) · UC San Diego · doi:10.7270/q2gt5sjt

BindingDB Entry 50044148: Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists.

BindingDB (2015) · UC San Diego · doi:10.7270/q2b859m5

BindingDB Entry 50039077: Synthesis and SAR of novel imidazoles as potent and selective cannabinoid CB2 receptor antagonists with high binding efficiencies.

BindingDB (2012) · UC San Diego · doi:10.7270/q22j6ctb

Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy

Valenzano, K. J., Tafesse, L., Lee, G., Harrison, J. E., Boulet, J. M., Gottshall, S. L., Mark, L., Pearson, M. S., Miller, W., Shan, S., et al. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.12.008 · Cited by 288 · see citing works

<i>In vitro</i>and<i>in vivo</i>characterization of A‐796260: a selective cannabinoid CB₂receptor agonist exhibiting analgesic activity in rodent pain models

Yao, B. B., Hsieh, G. C., Frost, J. M., Fan, Y., Garrison, T. R., Daza, A. V., Grayson, G. K., Zhu, C. Z., Pai, M., Chandran, P., et al. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707568 · Cited by 140 · see citing works

The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects

Kinsey, S. G., Mahadevan, A., Zhao, B., Sun, H., Naidu, P. S., Razdan, R. K., Selley, D. E., Damaj, M. I., & Lichtman, A. H. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.09.004 · Cited by 94 · see citing works

(211) CB2 agonists reduce carrageenan-induced thermal hyperalgesia and edema in mice via a non-CB2 receptor mechanism

Lehto, S. G., Guo, W., Malmberg, A. B., Huang, M., Cheng, Y., Tomlinson, S. A., DiMauro, E. F., Emkey, R., Huang, L., Magal, E., et al. (2008) · Journal of Pain · doi:10.1016/j.jpain.2008.01.132 · Cited by 2 · see citing works

A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833

Whiteside, G. T., Gottshall, S. L., Boulet, J. M., Chaffer, S. M., Harrison, J., Pearson, M. S., Turchin, P. I., Mark, L., Garrison, A. E., & Valenzano, K. J. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.10.043 · Cited by 94 · see citing works